Invention Grant
![Bis[thiohydrazide amide] compounds for treating leukemia](/docs/US/2014-09-02/US08822532B2/abs.jpg.600x600.jpg)
- Patent Title: Bis[thiohydrazide amide] compounds for treating leukemia
- Patent Title (中): 用于治疗白血病的双[硫代肼酰胺]化合物
-
Application No.: US13513449Application Date: 2010-12-06
-
Publication No.: US08822532B2Publication Date: 2014-09-02
- Inventor: Masazumi Nagai , Jianhua Shen
- Applicant: Masazumi Nagai , Jianhua Shen
- Applicant Address: US MA Lexington
- Assignee: Synta Pharmaceuticals Corp.
- Current Assignee: Synta Pharmaceuticals Corp.
- Current Assignee Address: US MA Lexington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis
- International Application: PCT/US2010/059109 WO 20101206
- International Announcement: WO2011/069159 WO 20110609
- Main IPC: A61K31/28
- IPC: A61K31/28 ; A61P35/02 ; A61K31/315
![Bis[thiohydrazide amide] compounds for treating leukemia](/abs-image/US/2014/09/02/US08822532B2/abs.jpg.150x150.jpg)
Abstract:
Certain bis[thio-hydrazide amide]-related compounds are found to be surprisingly effective at treating with leukemia, e.g., acute myeloid leukemia (AML). Methods of treating a subject with AML including administering bis[thio-hydrazide amide]-related compounds described herein, are disclosed.
Public/Granted literature
- US20130035386A1 BIS[THIOHYDRAZIDE AMIDE] COMPOUNDS FOR TREATING LEUKEMIA Public/Granted day:2013-02-07
Information query
